Animal models of cancer metastasis to the bone.
animal models
bone metastases
breast cancer
cell lines
prostate cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
02
2023
accepted:
10
03
2023
medline:
24
4
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
epublish
Résumé
Cancer metastasis is a major cause of mortality from several tumors, including those of the breast, prostate, and the thyroid gland. Since bone tissue is one of the most common sites of metastasis, the treatment of bone metastases is crucial for the cure of cancer. Hence, disease models must be developed to understand the process of bone metastasis in order to devise therapies for it. Several translational models of different bone metastatic tumors have been developed, including animal models, cell line injection models, bone implant models, and patient-derived xenograft models. However, a compendium on different bone metastatic cancers is currently not available. Here, we have compiled several animal models derived from current experiments on bone metastasis, mostly involving breast and prostate cancer, to improve the development of preclinical models and promote the treatment of bone metastasis.
Identifiants
pubmed: 37091152
doi: 10.3389/fonc.2023.1165380
pmc: PMC10113496
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1165380Informations de copyright
Copyright © 2023 Yu, Li, Peng, Wu, Chen, Shao and Zhang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Exp Clin Cancer Res. 2021 Mar 16;40(1):98
pubmed: 33722248
EBioMedicine. 2019 Jun;44:452-466
pubmed: 31151929
Anticancer Res. 2005 Mar-Apr;25(2A):1067-73
pubmed: 15868947
Cancer Invest. 2015;33(9):459-68
pubmed: 26305725
Mol Oncol. 2020 Apr;14(4):808-828
pubmed: 31925912
Nat Commun. 2022 Dec 12;13(1):7689
pubmed: 36509738
Theranostics. 2021 Mar 4;11(10):4770-4789
pubmed: 33754027
Thyroid. 2014 Apr;24(4):695-704
pubmed: 24262022
Elife. 2020 Sep 10;9:
pubmed: 32909943
J Bone Miner Res. 2020 Jan;35(1):155-166
pubmed: 31505052
In Vivo. 2022 Jul-Aug;36(4):1647-1650
pubmed: 35738622
Cell Death Dis. 2018 Jul 13;9(7):779
pubmed: 30006541
Bone Res. 2019 Oct 21;7:31
pubmed: 31646018
Cancers (Basel). 2020 Oct 16;12(10):
pubmed: 33081224
Carcinogenesis. 2020 Jul 10;41(5):551-560
pubmed: 31713604
Oncogene. 2020 Sep;39(36):5839-5854
pubmed: 32796959
Biochem Pharmacol. 2014 Sep 1;91(1):51-60
pubmed: 24929117
J Exp Clin Cancer Res. 2018 Aug 30;37(1):209
pubmed: 30165893
Oncogene. 2019 Jun;38(23):4540-4559
pubmed: 30755731
Int J Mol Sci. 2020 Dec 03;21(23):
pubmed: 33287358
Methods Mol Biol. 2019;1914:309-330
pubmed: 30729473
Oncogene. 2019 Jan;38(1):60-72
pubmed: 30076415
J Struct Biol. 2011 Feb;173(2):303-11
pubmed: 21081167
Asian J Androl. 2014 May-Jun;16(3):407-12
pubmed: 24589467
Sci Transl Med. 2021 Jul 21;13(603):
pubmed: 34290053
Front Oncol. 2022 May 30;12:907000
pubmed: 35707355
Cancer Cell Int. 2019 Oct 11;19:264
pubmed: 31632198
Mol Cancer Ther. 2020 Feb;19(2):650-660
pubmed: 31694887
Cancer Lett. 2022 Apr 1;530:156-169
pubmed: 35051532
J Bone Oncol. 2020 May 31;23:100298
pubmed: 32642420
Bone Res. 2022 Jan 20;10(1):6
pubmed: 35058441
Oncogene. 2020 Jan;39(1):204-218
pubmed: 31467432
Cancer Cell. 2017 Dec 11;32(6):731-747.e6
pubmed: 29232552
Theranostics. 2021 Mar 31;11(12):5794-5812
pubmed: 33897882
Cells. 2021 Feb 18;10(2):
pubmed: 33670586
Prostate. 2021 Jun;81(8):452-462
pubmed: 33822400
Int J Cancer. 2008 Feb 15;122(4):751-60
pubmed: 17960623
Cell Death Differ. 2022 Nov;29(11):2203-2217
pubmed: 35534547
Clin Cancer Res. 2009 Apr 1;15(7):2433-41
pubmed: 19318480
Nat Rev Urol. 2018 Jul;15(7):403-421
pubmed: 29769644
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E992-E1001
pubmed: 29339479
Cancers (Basel). 2022 Jan 22;14(3):
pubmed: 35158823
Nat Commun. 2021 Mar 17;12(1):1714
pubmed: 33731701
Clin Exp Metastasis. 2022 Jun;39(3):467-477
pubmed: 35103869
Mol Cancer Res. 2020 Mar;18(3):501-513
pubmed: 31722969
Cancer Immunol Res. 2021 Dec;9(12):1400-1412
pubmed: 34551967
Bone Res. 2021 May 14;9(1):24
pubmed: 33990538
Breast Cancer Res. 2022 Jan 25;24(1):7
pubmed: 35078507
Trends Cell Biol. 2022 Feb;32(2):110-123
pubmed: 34479765
Nat Commun. 2018 Jul 30;9(1):2981
pubmed: 30061695
Am J Transl Res. 2020 Sep 15;12(9):5619-5629
pubmed: 33042443
Nat Commun. 2021 Nov 26;12(1):6920
pubmed: 34836954
Mol Cancer. 2018 Jan 17;17(1):9
pubmed: 29343249
Small. 2022 Jul;18(29):e2107787
pubmed: 35751455
J Clin Invest. 2021 May 17;131(10):
pubmed: 33848267
Int J Cancer. 2020 Mar 1;146(5):1369-1382
pubmed: 31276604
Cancer Metastasis Rev. 2013 Jun;32(1-2):129-45
pubmed: 23657538
Nat Cell Biol. 2018 Feb;20(2):211-221
pubmed: 29358704
Int J Biol Sci. 2020 Jul 19;16(14):2580-2594
pubmed: 32792858
Cancers (Basel). 2020 Apr 03;12(4):
pubmed: 32260072
J Vis Exp. 2022 Nov 4;(189):
pubmed: 36408984
Bone. 2021 Mar;144:115775
pubmed: 33249323
Cancer Sci. 2021 Dec;112(12):4883-4893
pubmed: 34632664
Cancer Sci. 2022 Nov;113(11):3751-3765
pubmed: 35969372
Peptides. 2021 Jan;135:170423
pubmed: 33086087
Am J Cancer Res. 2020 Aug 01;10(8):2464-2479
pubmed: 32905535
J Clin Invest. 2022 Oct 17;132(20):
pubmed: 36006737
Cancer Res. 1996 Sep 15;56(18):4096-102
pubmed: 8797572
Oncogene. 2019 Aug;38(35):6241-6255
pubmed: 31312026
Cancer Res. 2020 Mar 15;80(6):1304-1315
pubmed: 31941699
Cancer Lett. 2018 Apr 1;418:109-118
pubmed: 29337106
Breast Cancer Res. 2005;7(4):R444-54
pubmed: 15987449
Cancer Res. 1992 Sep 1;52(17):4613-9
pubmed: 1511429
Cancer Sci. 2019 Oct;110(10):3157-3172
pubmed: 31432600
Prostate. 2009 Nov 1;69(15):1613-23
pubmed: 19585491
Nat Cancer. 2020 Nov;1(11):1082-1096
pubmed: 34085047
Eur Urol Oncol. 2022 Apr;5(2):164-175
pubmed: 34774481
Front Oncol. 2022 Apr 27;12:877536
pubmed: 35574356
Int J Mol Sci. 2016 Aug 22;17(8):
pubmed: 27556456
Cancer Res. 2021 Oct 15;81(20):5242-5254
pubmed: 34433585
Breast. 2013 Aug;22 Suppl 2:S50-6
pubmed: 24074793
Eur J Cancer. 2004 Apr;40(6):852-7
pubmed: 15120041
Am J Pathol. 2002 Mar;160(3):1143-53
pubmed: 11891210
Clin Exp Metastasis. 2005;22(8):605-14
pubmed: 16670964
Endocr Relat Cancer. 2014 Mar 07;21(2):327-41
pubmed: 24413608
Oncol Lett. 2019 Aug;18(2):1189-1198
pubmed: 31423179
Comp Med. 2009 Feb;59(1):37-45
pubmed: 19295053
Clin Exp Metastasis. 2006;23(7-8):345-56
pubmed: 17136574
Nat Commun. 2022 May 10;13(1):2543
pubmed: 35538070